A recent report has revealed that the screening of men falling in the age group of 50 and 65 years for prostate cancer can effectively reduce the risk of fatality by nearly 50%.
However, the researchers clarified that the study results do not imply that the screening programs get too common for all the men in the nation.
David Neal from Britain's Cambridge University, said, "It does not imply that PSA screening programs should now be introduced internationally".
In men suffering from any other forms of cancer, there is a possibility of enlargement of tumours due to the screening process, said the study.
Gothenburg University Researchers examined as many as 20,000 men, splitting them into equal groups. One group received the screening while the other didn’t.
The screening technique called prostate-specific antigen (PSA) testing is essentially used across the United States and a couple of other developed nations, in order to identify the cancer tumours.
The study that carried on for 14 years, found that the death rates reduced by nearly 50% among those, who received the screening, in contrast with those who didn’t receive the screening treatment.
Lead researcher said that screening can help in cutting cancer deaths in men by nearly half.